United States · Financial press · Investor's Business Daily
AbbVie's Earnings Double As Immunology Powerhouse Skyrizi Beats Again
AbbVie stock slipped slightly Friday, but the drug giant easily beat third-quarter forecasts with the help of its biggest drug, Skyrizi. The post AbbVie's Earnings Double As…
Read the full article on Investor's Business Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)
